Inspira Technologies Oxy B.H.N. Ltd. (IINN) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Raanana, Israel. The current CEO is Dagi Shahar Ben-Noon.
IINN has IPO date of 2021-07-14, 37 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $11.44M.
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.
